| J9271 | Injection, pembrolizumab, 1 mg | 17,800 | $40 | $765.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 790 | $90 | $71.9K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 3,700 | $20 | $62.9K |
| J0897 | Injection, denosumab, 1 mg | 2,760 | $20 | $49.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 430 | $90 | $40.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 580 | $60 | $32.9K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 220 | $100 | $22K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 220 | $90 | $19.4K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 230 | $70 | $16K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 1,550 | $10 | $12.4K |